The Brain Tumor Center’s basic, translational and clinical research programs are focused on understanding the biology of malignant and benign brain tumors, developing innovative treatments and bringing those innovations from our laboratories to our patients.
Established in 2021, the Brain Tumor Center is centered within the vibrant community of Washington University School of Medicine in St. Louis — a global leader in cancer biology, neuroscience, immunology, molecular imaging and high-speed comprehensive genomic and epigenetic research. Research laboratories from neurosurgery, neurology, medical and pediatric oncology, radiation oncology, radiology, immunology & pathology and genetics seek new treatments for the most common as well as rare brain tumors. Leveraging cutting-edge medical, surgical and radiation technologies at the Alvin J. Siteman Comprehensive Cancer Center, one of the nation’s elite cancer research institutions, and Barnes-Jewish Hospital and St. Louis Children’s Hospital, our physicians and scientists have developed a broad-based clinical research portfolio with over 35 ongoing clinical trials.
Beginning in 2023, the Brain Tumor Center research laboratories will be housed within the new $616 million, 11-story and 609,000 square-foot, state-of-the-art Neuroscience Research Building — which will be one of the largest neuroscience research buildings in the country. At the eastern edge of the Washington University Medical Campus, the building will sit in the 200-acre Cortex Innovation Community, one of the fastest-growing business, innovation and technology hubs in the United States. This infrastructure will enable and strengthen collaborations between academic research and industry partners, to rapidly translate fundamental science into advanced care for brain tumor patients.